1. pregnant 2. patients who participated in any interventional studies in the past 6 months 3. patients with severe hepatic impairment on admission (alanine aminotransferase higher than fivefold the upper limit) 4. patients taking any dopamine receptor antagonists 5. patient having history of hypersensitivity to pimozide 6. patients unable to comply with the study schedule 7. actively using cortiocosteroids

1. pregnant 2. patients who participated in any interventional studies in the past 6 months 3. patients with severe hepatic impairment on admission (alanine aminotransferase higher than fivefold the upper limit) 4. patients taking any dopamine receptor antagonists 5. patient having history of hypersensitivity to pimozide 6. patients unable to comply with the study schedule 7. actively using cortiocosteroids

pregnant patients who participated in any interventional studies in the past 6 months patients with severe hepatic impairment on admission (alanine aminotransferase higher than fivefold the upper limit) patients taking any dopamine receptor antagonists patient having history of hypersensitivity to pimozide patients unable to comply with the study schedule actively using cortiocosteroids

pregnant patients who participated in any interventional studies in the past 6 months patients with severe hepatic impairment on admission (alanine aminotransferase higher than fivefold the upper limit) patients taking any dopamine receptor antagonists patient having history of hypersensitivity to pimozide patients unable to comply with the study schedule actively using cortiocosteroids